Join to View Full Profile
451 E. Health Sciences DriveDavis, CA 95616
Phone+1 530-752-2884
Dr. Gershwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford University School of MedicineClass of 1971
Certifications & Licensure
NY State Medical License 1972 - Present
CA State Medical License 1974 - 2026
FL State Medical License 2012 - 2021
LA State Medical License 2018 - 2018
MD State Medical License 1973 - 1992
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Gut microbiome pattern impacts treatment response in primary biliary cholangitis.Qiaoyan Liu, Bingyuan Huang, Yijun Zhou, Yiran Wei, Yikang Li
Med. 2025-01-10 - Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis.Debby Reuveni, Siwar Assi, Yael Gore, Eli Brazowski, Patrick S C Leung
Liver International. 2024-08-01 - 5 citationsAutoimmune Hepatitis: Pathophysiology.Zhou Yuming, Tang Ruqi, Merrill Eric Gershwin, Ma Xiong
Clinics in Liver Disease. 2024-02-01
Grant Support
- New Therapy for the Treatment of Primary Biliary Cholangitis.EPIGEN BIOSCIENCES, INC.2023–2025
- New Therapy for the Treatment of Primary Biliary Cholangitis.EPIGEN BIOSCIENCES, INC.2023–2025
- Mechanistically based therapeutic strategies in murine primary biliary cholangitisUNIVERSITY OF CALIFORNIA AT DAVIS2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
